Clinical Trials on Recurrent Adult Non-Hodgkin Lymphoma in Colombia
Total 386 results
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
National Cancer Institute (NCI)CompletedAnaplastic Large Cell Lymphoma | Recurrent Adult Non-Hodgkin Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Adult Nasal Type Extranodal NK/T-Cell LymphomaUnited States, Canada
-
NCIC Clinical Trials GroupAstex Pharmaceuticals, Inc.CompletedUnspecified Adult Solid Tumor, Protocol Specific | Non-Hodgkins LymphomaCanada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Hodgkin Lymphoma | Refractory Childhood Hodgkin Lymphoma | Recurrent Childhood Hodgkin LymphomaUnited States, Canada
-
MorphotekNational Cancer Institute (NCI); Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Grade 3a Follicular Lymphoma | Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Mycosis Fungoides | Recurrent Primary Cutaneous... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)CompletedRecurrent Adult Lymphoblastic Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Genentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkins LymphomaUnited States, France, Canada, Netherlands
-
British Columbia Cancer AgencyHoffmann-La RocheActive, not recruitingLymphoma, Non-Hodgkin | Advanced Stage Diffuse Large B-Cell Non-Hodgkin's LymphomaCanada
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Recurrent Childhood Lymphoblastic Lymphoma | Childhood T Acute Lymphoblastic Leukemia | Childhood B Acute Lymphoblastic LeukemiaUnited States, Canada
-
Cortice Biosciences, Inc.CompletedNeoplasms | Hodgkin Disease | Non-Hodgkin LymphomaUnited States
-
Celgene CorporationPrologue Research InternationalCompletedNon-Hodgkins LymphomaUnited States, Canada
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Chronic Lymphocytic LeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Gilead Sciences; Celgene CorporationCompletedRecurrent Follicular LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
New York Medical CollegeJohns Hopkins University; M.D. Anderson Cancer Center; Baylor College of Medicine and other collaboratorsCompletedNon-Hodgkins Lymphoma | Lymphoproliferative Disorder | Hodgkins LymphomaUnited States
-
Lundbeck Canada Inc.CompletedChronic Lymphocytic Leukemia | Indolent Non-Hodgkin's LymphomaCanada
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Pacylex PharmaceuticalsOzmosis Research Inc.RecruitingAdvanced Solid Tumor | B-cell Non Hodgkin LymphomaCanada
-
Century Therapeutics, Inc.RecruitingAggressive Non-Hodgkin Lymphoma | R/R CD19-Positive B-Cell Malignancies | Indolent Non-Hodgkin LymphomaUnited States
-
National Cancer Institute (NCI)Completed
-
Georgetown UniversityCelgene Corporation; CephalonCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
NCIC Clinical Trials GroupCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
National Cancer Institute (NCI)CompletedHIV Infection | Clear Cell Renal Cell Carcinoma | Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Metastatic Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Refractory Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Canada
-
Parker Hughes Cancer CenterUnknownLymphoma | LeukemiaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Recurrent B Lymphoblastic Lymphoma | Refractory B Lymphoblastic LymphomaUnited States, Puerto Rico
-
National Cancer Institute (NCI)TerminatedUnspecified Childhood Solid Tumor, Protocol Specific | Peripheral T-cell Lymphoma | Angioimmunoblastic T-cell Lymphoma | Childhood Chronic Myelogenous Leukemia | Cutaneous B-cell Non-Hodgkin Lymphoma | Hepatosplenic T-cell Lymphoma | Intraocular Lymphoma | Recurrent Childhood Acute Lymphoblastic... and other conditionsUnited States, Canada
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaColombia, Mexico
-
Ascenta TherapeuticsCompletedFollicular LymphomaUnited States
-
Medstar Health Research InstituteWithdrawn
-
Geriatric Oncology ConsortiumTibotec Pharmaceutical LimitedTerminatedNon-Hodgkin's LymphomaUnited States
-
Kite, A Gilead CompanyActive, not recruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-Hodgkin LymphomaUnited States, France
-
University of Alabama at BirminghamNational Cancer Institute (NCI); BiogenCompletedLymphomaUnited States
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
Bristol-Myers SquibbSeagen Inc.CompletedNon-Hodgkin's DiseaseUnited States, France, Canada, United Kingdom, Italy, Spain
-
BayerCompletedMedical OncologyCanada, United States
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
BiogenCompletedLow-Grade or Follicular B-Cell Non-Hodgkin's LymphomaUnited States, Canada
-
BiogenCompletedNon-Hodgkin's LymphomaUnited States
-
AstraZenecaParexelActive, not recruitingRelapsed or Refractory B-cell Non-Hodgkin LymphomaUnited States, Korea, Republic of, Canada, United Kingdom, Spain, France, Denmark
-
Novartis PharmaceuticalsGlaxoSmithKlineTerminatedNon-Hodgkin's LymphomaChina, United States, Belgium, Czechia, France, Japan, Bulgaria, Canada, Hungary, Peru, Slovakia, South Africa, Ukraine, Korea, Republic of, Puerto Rico, Brazil
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingAnaplastic Large Cell Lymphoma, ALK-Positive | Adult T-Cell Leukemia/Lymphoma | Angioimmunoblastic T-Cell Lymphoma | Hepatosplenic T-Cell Lymphoma | Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Anaplastic... and other conditionsUnited States, Canada
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more